When Thamy Lor started with Biocut Systems in 2013, he says he was just a kid looking for a job. His search landed him in the shipping and receiving department. Now as the company’s operations manager, his responsibilities have grown as has his experience and knowledge with die-making.
“The most critical detail in designing dies would be strength, quality and longevity of the die” said Lor.
Like all Biocut projects, the die-making process starts with a conversation with the client. These conversations are then transformed into drawings that are later constructed into prototypes.
Certain factors are taken into consideration for customers. And whether it be budget or safety, adjustments can be made to meet customer satisfaction.
“Some customers come to us and say ‘This die is a little dangerous to handle. Can we add handles, etc? Can we modify this?’ And that’s sort of what we do. We are a solutions company so we design things based on what the customer will want.”
Engineers are sure to consider that these cookie-cutter resembling tools are able to withstand quality inspections when it comes to sterilization protocols and other possible heating and cooling and tests.
In 2019, Biocut Systems received a U.S. patent for their premier SterilCut® interlocking polycarbonate base with 301 stainless steel blades; Lor being one of the lead inventors. The company has utilized these trusted technologies for ten years and have developed meshing, cancellous bone cubing and amnion mincing dies to streamline production, improve safety, accuracy and yield.
“These dies expand when they’re autoclaved and their parts get moved around. So with this interlocking base we can develop a die that can withstand sterilization and autoclaving,” said Lor. “When that process is done, the dies can conform back to their original shape and the accuracy of the dies stay within tolerance.”
Lor’s hope is that the company can continue to lead their industry with innovative technologies that improve functionality and user experience for clients, overall benefiting the people on the receiving end of clients’ services whether through tissue transplants or other treatments.